Clinical trial
Evaluation of SWE as a Predictive Tool for Progression of Chronic Liver Diseases
NCT03389152 is registered in ClinicalTrials.gov with SuperSonic Imagine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of SWE as a Predictive Tool for Progression of Chronic Liver Diseases
- Lead sponsor
- SuperSonic Imagine
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 26, 2007
- Completion date
- November 28, 2019
- Enrollment
- 2,148 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
liver fibroses